Global Oral TYK2 Inhibitors Market Growth 2026-2032
The global Oral TYK2 Inhibitors market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Oral TYK2 allosteric inhibitors are oral drugs that exert their therapeutic effects by selectively inhibiting tyrosine kinase 2 (TYK2). TYK2 is a kinase that plays a key role in the immune system and is involved in the signaling of multiple cytokines that play an important role in immune-mediated diseases. Oral TYK2 allosteric inhibitors specifically bind to the regulatory domain of TYK2, blocking the signaling of these cytokines, thereby inhibiting the pathological processes of autoimmune and inflammatory diseases.
United States market for Oral TYK2 Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Oral TYK2 Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Oral TYK2 Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Oral TYK2 Inhibitors players cover Bristol Myers Squibb, InnoCare, Takeda (Nimbus Therapeutics), Inventisbio, Changzhou Hengbang Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Oral TYK2 Inhibitors Industry Forecast” looks at past sales and reviews total world Oral TYK2 Inhibitors sales in 2025, providing a comprehensive analysis by region and market sector of projected Oral TYK2 Inhibitors sales for 2026 through 2032. With Oral TYK2 Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral TYK2 Inhibitors industry.
This Insight Report provides a comprehensive analysis of the global Oral TYK2 Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral TYK2 Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral TYK2 Inhibitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral TYK2 Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral TYK2 Inhibitors.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral TYK2 Inhibitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Oral TYK2 Inhibitors market?
What factors are driving Oral TYK2 Inhibitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral TYK2 Inhibitors market opportunities vary by end market size?
How does Oral TYK2 Inhibitors break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Oral TYK2 allosteric inhibitors are oral drugs that exert their therapeutic effects by selectively inhibiting tyrosine kinase 2 (TYK2). TYK2 is a kinase that plays a key role in the immune system and is involved in the signaling of multiple cytokines that play an important role in immune-mediated diseases. Oral TYK2 allosteric inhibitors specifically bind to the regulatory domain of TYK2, blocking the signaling of these cytokines, thereby inhibiting the pathological processes of autoimmune and inflammatory diseases.
United States market for Oral TYK2 Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Oral TYK2 Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Oral TYK2 Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Oral TYK2 Inhibitors players cover Bristol Myers Squibb, InnoCare, Takeda (Nimbus Therapeutics), Inventisbio, Changzhou Hengbang Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Oral TYK2 Inhibitors Industry Forecast” looks at past sales and reviews total world Oral TYK2 Inhibitors sales in 2025, providing a comprehensive analysis by region and market sector of projected Oral TYK2 Inhibitors sales for 2026 through 2032. With Oral TYK2 Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral TYK2 Inhibitors industry.
This Insight Report provides a comprehensive analysis of the global Oral TYK2 Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral TYK2 Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral TYK2 Inhibitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral TYK2 Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral TYK2 Inhibitors.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral TYK2 Inhibitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Single-target Inhibitors
- Dual-target Inhibitors
- Psoriasis
- Systemic Lupus Erythematosus
- Dermatitis
- Arthritis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol Myers Squibb
- InnoCare
- Takeda (Nimbus Therapeutics)
- Inventisbio
- Changzhou Hengbang Pharmaceutical
- Ventyx Biosciences
- Galapagos NV
- Highlightll Pharma
What is the 10-year outlook for the global Oral TYK2 Inhibitors market?
What factors are driving Oral TYK2 Inhibitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral TYK2 Inhibitors market opportunities vary by end market size?
How does Oral TYK2 Inhibitors break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral TYK2 Inhibitors Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Oral TYK2 Inhibitors by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Oral TYK2 Inhibitors by Country/Region, 2021, 2025 & 2032
2.2 Oral TYK2 Inhibitors Segment by Type
2.2.1 Single-target Inhibitors
2.2.2 Dual-target Inhibitors
2.2.3 Oral TYK2 Inhibitors Sales by Type
2.2.3.1 Global Oral TYK2 Inhibitors Sales Market Share by Type (2021-2026)
2.2.3.2 Global Oral TYK2 Inhibitors Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Oral TYK2 Inhibitors Sale Price by Type (2021-2026)
2.3 Oral TYK2 Inhibitors Segment by Application
2.3.1 Psoriasis
2.3.2 Systemic Lupus Erythematosus
2.3.3 Dermatitis
2.3.4 Arthritis
2.3.5 Others
2.3.6 Oral TYK2 Inhibitors Sales by Application
2.3.6.1 Global Oral TYK2 Inhibitors Sale Market Share by Application (2021-2026)
2.3.6.2 Global Oral TYK2 Inhibitors Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Oral TYK2 Inhibitors Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Oral TYK2 Inhibitors Breakdown Data by Company
3.1.1 Global Oral TYK2 Inhibitors Annual Sales by Company (2021-2026)
3.1.2 Global Oral TYK2 Inhibitors Sales Market Share by Company (2021-2026)
3.2 Global Oral TYK2 Inhibitors Annual Revenue by Company (2021-2026)
3.2.1 Global Oral TYK2 Inhibitors Revenue by Company (2021-2026)
3.2.2 Global Oral TYK2 Inhibitors Revenue Market Share by Company (2021-2026)
3.3 Global Oral TYK2 Inhibitors Sale Price by Company
3.4 Key Manufacturers Oral TYK2 Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral TYK2 Inhibitors Product Location Distribution
3.4.2 Players Oral TYK2 Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORAL TYK2 INHIBITORS BY GEOGRAPHIC REGION
4.1 World Historic Oral TYK2 Inhibitors Market Size by Geographic Region (2021-2026)
4.1.1 Global Oral TYK2 Inhibitors Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Oral TYK2 Inhibitors Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Oral TYK2 Inhibitors Market Size by Country/Region (2021-2026)
4.2.1 Global Oral TYK2 Inhibitors Annual Sales by Country/Region (2021-2026)
4.2.2 Global Oral TYK2 Inhibitors Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oral TYK2 Inhibitors Sales Growth
4.4 APAC Oral TYK2 Inhibitors Sales Growth
4.5 Europe Oral TYK2 Inhibitors Sales Growth
4.6 Middle East & Africa Oral TYK2 Inhibitors Sales Growth
5 AMERICAS
5.1 Americas Oral TYK2 Inhibitors Sales by Country
5.1.1 Americas Oral TYK2 Inhibitors Sales by Country (2021-2026)
5.1.2 Americas Oral TYK2 Inhibitors Revenue by Country (2021-2026)
5.2 Americas Oral TYK2 Inhibitors Sales by Type (2021-2026)
5.3 Americas Oral TYK2 Inhibitors Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral TYK2 Inhibitors Sales by Region
6.1.1 APAC Oral TYK2 Inhibitors Sales by Region (2021-2026)
6.1.2 APAC Oral TYK2 Inhibitors Revenue by Region (2021-2026)
6.2 APAC Oral TYK2 Inhibitors Sales by Type (2021-2026)
6.3 APAC Oral TYK2 Inhibitors Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral TYK2 Inhibitors by Country
7.1.1 Europe Oral TYK2 Inhibitors Sales by Country (2021-2026)
7.1.2 Europe Oral TYK2 Inhibitors Revenue by Country (2021-2026)
7.2 Europe Oral TYK2 Inhibitors Sales by Type (2021-2026)
7.3 Europe Oral TYK2 Inhibitors Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral TYK2 Inhibitors by Country
8.1.1 Middle East & Africa Oral TYK2 Inhibitors Sales by Country (2021-2026)
8.1.2 Middle East & Africa Oral TYK2 Inhibitors Revenue by Country (2021-2026)
8.2 Middle East & Africa Oral TYK2 Inhibitors Sales by Type (2021-2026)
8.3 Middle East & Africa Oral TYK2 Inhibitors Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral TYK2 Inhibitors
10.3 Manufacturing Process Analysis of Oral TYK2 Inhibitors
10.4 Industry Chain Structure of Oral TYK2 Inhibitors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral TYK2 Inhibitors Distributors
11.3 Oral TYK2 Inhibitors Customer
12 WORLD FORECAST REVIEW FOR ORAL TYK2 INHIBITORS BY GEOGRAPHIC REGION
12.1 Global Oral TYK2 Inhibitors Market Size Forecast by Region
12.1.1 Global Oral TYK2 Inhibitors Forecast by Region (2027-2032)
12.1.2 Global Oral TYK2 Inhibitors Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Oral TYK2 Inhibitors Forecast by Type (2027-2032)
12.7 Global Oral TYK2 Inhibitors Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bristol Myers Squibb
13.1.1 Bristol Myers Squibb Company Information
13.1.2 Bristol Myers Squibb Oral TYK2 Inhibitors Product Portfolios and Specifications
13.1.3 Bristol Myers Squibb Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bristol Myers Squibb Main Business Overview
13.1.5 Bristol Myers Squibb Latest Developments
13.2 InnoCare
13.2.1 InnoCare Company Information
13.2.2 InnoCare Oral TYK2 Inhibitors Product Portfolios and Specifications
13.2.3 InnoCare Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 InnoCare Main Business Overview
13.2.5 InnoCare Latest Developments
13.3 Takeda (Nimbus Therapeutics)
13.3.1 Takeda (Nimbus Therapeutics) Company Information
13.3.2 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Product Portfolios and Specifications
13.3.3 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Takeda (Nimbus Therapeutics) Main Business Overview
13.3.5 Takeda (Nimbus Therapeutics) Latest Developments
13.4 Inventisbio
13.4.1 Inventisbio Company Information
13.4.2 Inventisbio Oral TYK2 Inhibitors Product Portfolios and Specifications
13.4.3 Inventisbio Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Inventisbio Main Business Overview
13.4.5 Inventisbio Latest Developments
13.5 Changzhou Hengbang Pharmaceutical
13.5.1 Changzhou Hengbang Pharmaceutical Company Information
13.5.2 Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Product Portfolios and Specifications
13.5.3 Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Changzhou Hengbang Pharmaceutical Main Business Overview
13.5.5 Changzhou Hengbang Pharmaceutical Latest Developments
13.6 Ventyx Biosciences
13.6.1 Ventyx Biosciences Company Information
13.6.2 Ventyx Biosciences Oral TYK2 Inhibitors Product Portfolios and Specifications
13.6.3 Ventyx Biosciences Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Ventyx Biosciences Main Business Overview
13.6.5 Ventyx Biosciences Latest Developments
13.7 Galapagos NV
13.7.1 Galapagos NV Company Information
13.7.2 Galapagos NV Oral TYK2 Inhibitors Product Portfolios and Specifications
13.7.3 Galapagos NV Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Galapagos NV Main Business Overview
13.7.5 Galapagos NV Latest Developments
13.8 Highlightll Pharma
13.8.1 Highlightll Pharma Company Information
13.8.2 Highlightll Pharma Oral TYK2 Inhibitors Product Portfolios and Specifications
13.8.3 Highlightll Pharma Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Highlightll Pharma Main Business Overview
13.8.5 Highlightll Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral TYK2 Inhibitors Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Oral TYK2 Inhibitors by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Oral TYK2 Inhibitors by Country/Region, 2021, 2025 & 2032
2.2 Oral TYK2 Inhibitors Segment by Type
2.2.1 Single-target Inhibitors
2.2.2 Dual-target Inhibitors
2.2.3 Oral TYK2 Inhibitors Sales by Type
2.2.3.1 Global Oral TYK2 Inhibitors Sales Market Share by Type (2021-2026)
2.2.3.2 Global Oral TYK2 Inhibitors Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Oral TYK2 Inhibitors Sale Price by Type (2021-2026)
2.3 Oral TYK2 Inhibitors Segment by Application
2.3.1 Psoriasis
2.3.2 Systemic Lupus Erythematosus
2.3.3 Dermatitis
2.3.4 Arthritis
2.3.5 Others
2.3.6 Oral TYK2 Inhibitors Sales by Application
2.3.6.1 Global Oral TYK2 Inhibitors Sale Market Share by Application (2021-2026)
2.3.6.2 Global Oral TYK2 Inhibitors Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Oral TYK2 Inhibitors Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Oral TYK2 Inhibitors Breakdown Data by Company
3.1.1 Global Oral TYK2 Inhibitors Annual Sales by Company (2021-2026)
3.1.2 Global Oral TYK2 Inhibitors Sales Market Share by Company (2021-2026)
3.2 Global Oral TYK2 Inhibitors Annual Revenue by Company (2021-2026)
3.2.1 Global Oral TYK2 Inhibitors Revenue by Company (2021-2026)
3.2.2 Global Oral TYK2 Inhibitors Revenue Market Share by Company (2021-2026)
3.3 Global Oral TYK2 Inhibitors Sale Price by Company
3.4 Key Manufacturers Oral TYK2 Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral TYK2 Inhibitors Product Location Distribution
3.4.2 Players Oral TYK2 Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORAL TYK2 INHIBITORS BY GEOGRAPHIC REGION
4.1 World Historic Oral TYK2 Inhibitors Market Size by Geographic Region (2021-2026)
4.1.1 Global Oral TYK2 Inhibitors Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Oral TYK2 Inhibitors Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Oral TYK2 Inhibitors Market Size by Country/Region (2021-2026)
4.2.1 Global Oral TYK2 Inhibitors Annual Sales by Country/Region (2021-2026)
4.2.2 Global Oral TYK2 Inhibitors Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oral TYK2 Inhibitors Sales Growth
4.4 APAC Oral TYK2 Inhibitors Sales Growth
4.5 Europe Oral TYK2 Inhibitors Sales Growth
4.6 Middle East & Africa Oral TYK2 Inhibitors Sales Growth
5 AMERICAS
5.1 Americas Oral TYK2 Inhibitors Sales by Country
5.1.1 Americas Oral TYK2 Inhibitors Sales by Country (2021-2026)
5.1.2 Americas Oral TYK2 Inhibitors Revenue by Country (2021-2026)
5.2 Americas Oral TYK2 Inhibitors Sales by Type (2021-2026)
5.3 Americas Oral TYK2 Inhibitors Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral TYK2 Inhibitors Sales by Region
6.1.1 APAC Oral TYK2 Inhibitors Sales by Region (2021-2026)
6.1.2 APAC Oral TYK2 Inhibitors Revenue by Region (2021-2026)
6.2 APAC Oral TYK2 Inhibitors Sales by Type (2021-2026)
6.3 APAC Oral TYK2 Inhibitors Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral TYK2 Inhibitors by Country
7.1.1 Europe Oral TYK2 Inhibitors Sales by Country (2021-2026)
7.1.2 Europe Oral TYK2 Inhibitors Revenue by Country (2021-2026)
7.2 Europe Oral TYK2 Inhibitors Sales by Type (2021-2026)
7.3 Europe Oral TYK2 Inhibitors Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral TYK2 Inhibitors by Country
8.1.1 Middle East & Africa Oral TYK2 Inhibitors Sales by Country (2021-2026)
8.1.2 Middle East & Africa Oral TYK2 Inhibitors Revenue by Country (2021-2026)
8.2 Middle East & Africa Oral TYK2 Inhibitors Sales by Type (2021-2026)
8.3 Middle East & Africa Oral TYK2 Inhibitors Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral TYK2 Inhibitors
10.3 Manufacturing Process Analysis of Oral TYK2 Inhibitors
10.4 Industry Chain Structure of Oral TYK2 Inhibitors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral TYK2 Inhibitors Distributors
11.3 Oral TYK2 Inhibitors Customer
12 WORLD FORECAST REVIEW FOR ORAL TYK2 INHIBITORS BY GEOGRAPHIC REGION
12.1 Global Oral TYK2 Inhibitors Market Size Forecast by Region
12.1.1 Global Oral TYK2 Inhibitors Forecast by Region (2027-2032)
12.1.2 Global Oral TYK2 Inhibitors Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Oral TYK2 Inhibitors Forecast by Type (2027-2032)
12.7 Global Oral TYK2 Inhibitors Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bristol Myers Squibb
13.1.1 Bristol Myers Squibb Company Information
13.1.2 Bristol Myers Squibb Oral TYK2 Inhibitors Product Portfolios and Specifications
13.1.3 Bristol Myers Squibb Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bristol Myers Squibb Main Business Overview
13.1.5 Bristol Myers Squibb Latest Developments
13.2 InnoCare
13.2.1 InnoCare Company Information
13.2.2 InnoCare Oral TYK2 Inhibitors Product Portfolios and Specifications
13.2.3 InnoCare Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 InnoCare Main Business Overview
13.2.5 InnoCare Latest Developments
13.3 Takeda (Nimbus Therapeutics)
13.3.1 Takeda (Nimbus Therapeutics) Company Information
13.3.2 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Product Portfolios and Specifications
13.3.3 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Takeda (Nimbus Therapeutics) Main Business Overview
13.3.5 Takeda (Nimbus Therapeutics) Latest Developments
13.4 Inventisbio
13.4.1 Inventisbio Company Information
13.4.2 Inventisbio Oral TYK2 Inhibitors Product Portfolios and Specifications
13.4.3 Inventisbio Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Inventisbio Main Business Overview
13.4.5 Inventisbio Latest Developments
13.5 Changzhou Hengbang Pharmaceutical
13.5.1 Changzhou Hengbang Pharmaceutical Company Information
13.5.2 Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Product Portfolios and Specifications
13.5.3 Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Changzhou Hengbang Pharmaceutical Main Business Overview
13.5.5 Changzhou Hengbang Pharmaceutical Latest Developments
13.6 Ventyx Biosciences
13.6.1 Ventyx Biosciences Company Information
13.6.2 Ventyx Biosciences Oral TYK2 Inhibitors Product Portfolios and Specifications
13.6.3 Ventyx Biosciences Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Ventyx Biosciences Main Business Overview
13.6.5 Ventyx Biosciences Latest Developments
13.7 Galapagos NV
13.7.1 Galapagos NV Company Information
13.7.2 Galapagos NV Oral TYK2 Inhibitors Product Portfolios and Specifications
13.7.3 Galapagos NV Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Galapagos NV Main Business Overview
13.7.5 Galapagos NV Latest Developments
13.8 Highlightll Pharma
13.8.1 Highlightll Pharma Company Information
13.8.2 Highlightll Pharma Oral TYK2 Inhibitors Product Portfolios and Specifications
13.8.3 Highlightll Pharma Oral TYK2 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Highlightll Pharma Main Business Overview
13.8.5 Highlightll Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oral TYK2 Inhibitors Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Oral TYK2 Inhibitors Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single-target Inhibitors
Table 4. Major Players of Dual-target Inhibitors
Table 5. Global Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 6. Global Oral TYK2 Inhibitors Sales Market Share by Type (2021-2026)
Table 7. Global Oral TYK2 Inhibitors Revenue by Type (2021-2026) & ($ million)
Table 8. Global Oral TYK2 Inhibitors Revenue Market Share by Type (2021-2026)
Table 9. Global Oral TYK2 Inhibitors Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Oral TYK2 Inhibitors Sale by Application (2021-2026) & (K Units)
Table 11. Global Oral TYK2 Inhibitors Sale Market Share by Application (2021-2026)
Table 12. Global Oral TYK2 Inhibitors Revenue by Application (2021-2026) & ($ million)
Table 13. Global Oral TYK2 Inhibitors Revenue Market Share by Application (2021-2026)
Table 14. Global Oral TYK2 Inhibitors Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Oral TYK2 Inhibitors Sales by Company (2021-2026) & (K Units)
Table 16. Global Oral TYK2 Inhibitors Sales Market Share by Company (2021-2026)
Table 17. Global Oral TYK2 Inhibitors Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Oral TYK2 Inhibitors Revenue Market Share by Company (2021-2026)
Table 19. Global Oral TYK2 Inhibitors Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Oral TYK2 Inhibitors Producing Area Distribution and Sales Area
Table 21. Players Oral TYK2 Inhibitors Products Offered
Table 22. Oral TYK2 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Oral TYK2 Inhibitors Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Oral TYK2 Inhibitors Sales Market Share Geographic Region (2021-2026)
Table 27. Global Oral TYK2 Inhibitors Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Oral TYK2 Inhibitors Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Oral TYK2 Inhibitors Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Oral TYK2 Inhibitors Sales Market Share by Country/Region (2021-2026)
Table 31. Global Oral TYK2 Inhibitors Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Oral TYK2 Inhibitors Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units)
Table 34. Americas Oral TYK2 Inhibitors Sales Market Share by Country (2021-2026)
Table 35. Americas Oral TYK2 Inhibitors Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 37. Americas Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 38. APAC Oral TYK2 Inhibitors Sales by Region (2021-2026) & (K Units)
Table 39. APAC Oral TYK2 Inhibitors Sales Market Share by Region (2021-2026)
Table 40. APAC Oral TYK2 Inhibitors Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 42. APAC Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 43. Europe Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units)
Table 44. Europe Oral TYK2 Inhibitors Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 46. Europe Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Oral TYK2 Inhibitors Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Oral TYK2 Inhibitors
Table 52. Key Market Challenges & Risks of Oral TYK2 Inhibitors
Table 53. Key Industry Trends of Oral TYK2 Inhibitors
Table 54. Oral TYK2 Inhibitors Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Oral TYK2 Inhibitors Distributors List
Table 57. Oral TYK2 Inhibitors Customer List
Table 58. Global Oral TYK2 Inhibitors Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Oral TYK2 Inhibitors Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Oral TYK2 Inhibitors Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Oral TYK2 Inhibitors Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Oral TYK2 Inhibitors Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Oral TYK2 Inhibitors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Oral TYK2 Inhibitors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Oral TYK2 Inhibitors Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Oral TYK2 Inhibitors Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Oral TYK2 Inhibitors Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Oral TYK2 Inhibitors Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Bristol Myers Squibb Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 73. Bristol Myers Squibb Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 74. Bristol Myers Squibb Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Bristol Myers Squibb Main Business
Table 76. Bristol Myers Squibb Latest Developments
Table 77. InnoCare Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 78. InnoCare Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 79. InnoCare Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. InnoCare Main Business
Table 81. InnoCare Latest Developments
Table 82. Takeda (Nimbus Therapeutics) Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 83. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 84. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Takeda (Nimbus Therapeutics) Main Business
Table 86. Takeda (Nimbus Therapeutics) Latest Developments
Table 87. Inventisbio Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 88. Inventisbio Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 89. Inventisbio Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Inventisbio Main Business
Table 91. Inventisbio Latest Developments
Table 92. Changzhou Hengbang Pharmaceutical Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 93. Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 94. Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Changzhou Hengbang Pharmaceutical Main Business
Table 96. Changzhou Hengbang Pharmaceutical Latest Developments
Table 97. Ventyx Biosciences Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 98. Ventyx Biosciences Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 99. Ventyx Biosciences Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Ventyx Biosciences Main Business
Table 101. Ventyx Biosciences Latest Developments
Table 102. Galapagos NV Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 103. Galapagos NV Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 104. Galapagos NV Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Galapagos NV Main Business
Table 106. Galapagos NV Latest Developments
Table 107. Highlightll Pharma Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 108. Highlightll Pharma Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 109. Highlightll Pharma Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Highlightll Pharma Main Business
Table 111. Highlightll Pharma Latest Developments
Table 1. Oral TYK2 Inhibitors Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Oral TYK2 Inhibitors Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single-target Inhibitors
Table 4. Major Players of Dual-target Inhibitors
Table 5. Global Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 6. Global Oral TYK2 Inhibitors Sales Market Share by Type (2021-2026)
Table 7. Global Oral TYK2 Inhibitors Revenue by Type (2021-2026) & ($ million)
Table 8. Global Oral TYK2 Inhibitors Revenue Market Share by Type (2021-2026)
Table 9. Global Oral TYK2 Inhibitors Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Oral TYK2 Inhibitors Sale by Application (2021-2026) & (K Units)
Table 11. Global Oral TYK2 Inhibitors Sale Market Share by Application (2021-2026)
Table 12. Global Oral TYK2 Inhibitors Revenue by Application (2021-2026) & ($ million)
Table 13. Global Oral TYK2 Inhibitors Revenue Market Share by Application (2021-2026)
Table 14. Global Oral TYK2 Inhibitors Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Oral TYK2 Inhibitors Sales by Company (2021-2026) & (K Units)
Table 16. Global Oral TYK2 Inhibitors Sales Market Share by Company (2021-2026)
Table 17. Global Oral TYK2 Inhibitors Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Oral TYK2 Inhibitors Revenue Market Share by Company (2021-2026)
Table 19. Global Oral TYK2 Inhibitors Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Oral TYK2 Inhibitors Producing Area Distribution and Sales Area
Table 21. Players Oral TYK2 Inhibitors Products Offered
Table 22. Oral TYK2 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Oral TYK2 Inhibitors Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Oral TYK2 Inhibitors Sales Market Share Geographic Region (2021-2026)
Table 27. Global Oral TYK2 Inhibitors Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Oral TYK2 Inhibitors Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Oral TYK2 Inhibitors Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Oral TYK2 Inhibitors Sales Market Share by Country/Region (2021-2026)
Table 31. Global Oral TYK2 Inhibitors Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Oral TYK2 Inhibitors Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units)
Table 34. Americas Oral TYK2 Inhibitors Sales Market Share by Country (2021-2026)
Table 35. Americas Oral TYK2 Inhibitors Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 37. Americas Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 38. APAC Oral TYK2 Inhibitors Sales by Region (2021-2026) & (K Units)
Table 39. APAC Oral TYK2 Inhibitors Sales Market Share by Region (2021-2026)
Table 40. APAC Oral TYK2 Inhibitors Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 42. APAC Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 43. Europe Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units)
Table 44. Europe Oral TYK2 Inhibitors Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 46. Europe Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Oral TYK2 Inhibitors Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Oral TYK2 Inhibitors
Table 52. Key Market Challenges & Risks of Oral TYK2 Inhibitors
Table 53. Key Industry Trends of Oral TYK2 Inhibitors
Table 54. Oral TYK2 Inhibitors Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Oral TYK2 Inhibitors Distributors List
Table 57. Oral TYK2 Inhibitors Customer List
Table 58. Global Oral TYK2 Inhibitors Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Oral TYK2 Inhibitors Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Oral TYK2 Inhibitors Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Oral TYK2 Inhibitors Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Oral TYK2 Inhibitors Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Oral TYK2 Inhibitors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Oral TYK2 Inhibitors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Oral TYK2 Inhibitors Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Oral TYK2 Inhibitors Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Oral TYK2 Inhibitors Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Oral TYK2 Inhibitors Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Bristol Myers Squibb Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 73. Bristol Myers Squibb Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 74. Bristol Myers Squibb Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Bristol Myers Squibb Main Business
Table 76. Bristol Myers Squibb Latest Developments
Table 77. InnoCare Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 78. InnoCare Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 79. InnoCare Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. InnoCare Main Business
Table 81. InnoCare Latest Developments
Table 82. Takeda (Nimbus Therapeutics) Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 83. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 84. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Takeda (Nimbus Therapeutics) Main Business
Table 86. Takeda (Nimbus Therapeutics) Latest Developments
Table 87. Inventisbio Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 88. Inventisbio Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 89. Inventisbio Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Inventisbio Main Business
Table 91. Inventisbio Latest Developments
Table 92. Changzhou Hengbang Pharmaceutical Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 93. Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 94. Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Changzhou Hengbang Pharmaceutical Main Business
Table 96. Changzhou Hengbang Pharmaceutical Latest Developments
Table 97. Ventyx Biosciences Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 98. Ventyx Biosciences Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 99. Ventyx Biosciences Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Ventyx Biosciences Main Business
Table 101. Ventyx Biosciences Latest Developments
Table 102. Galapagos NV Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 103. Galapagos NV Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 104. Galapagos NV Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Galapagos NV Main Business
Table 106. Galapagos NV Latest Developments
Table 107. Highlightll Pharma Basic Information, Oral TYK2 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 108. Highlightll Pharma Oral TYK2 Inhibitors Product Portfolios and Specifications
Table 109. Highlightll Pharma Oral TYK2 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Highlightll Pharma Main Business
Table 111. Highlightll Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oral TYK2 Inhibitors
Figure 2. Oral TYK2 Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral TYK2 Inhibitors Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Oral TYK2 Inhibitors Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Oral TYK2 Inhibitors Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Oral TYK2 Inhibitors Sales Market Share by Country/Region (2025)
Figure 10. Oral TYK2 Inhibitors Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Single-target Inhibitors
Figure 12. Product Picture of Dual-target Inhibitors
Figure 13. Global Oral TYK2 Inhibitors Sales Market Share by Type in 2026
Figure 14. Global Oral TYK2 Inhibitors Revenue Market Share by Type (2021-2026)
Figure 15. Oral TYK2 Inhibitors Consumed in Psoriasis
Figure 16. Global Oral TYK2 Inhibitors Market: Psoriasis (2021-2026) & (K Units)
Figure 17. Oral TYK2 Inhibitors Consumed in Systemic Lupus Erythematosus
Figure 18. Global Oral TYK2 Inhibitors Market: Systemic Lupus Erythematosus (2021-2026) & (K Units)
Figure 19. Oral TYK2 Inhibitors Consumed in Dermatitis
Figure 20. Global Oral TYK2 Inhibitors Market: Dermatitis (2021-2026) & (K Units)
Figure 21. Oral TYK2 Inhibitors Consumed in Arthritis
Figure 22. Global Oral TYK2 Inhibitors Market: Arthritis (2021-2026) & (K Units)
Figure 23. Oral TYK2 Inhibitors Consumed in Others
Figure 24. Global Oral TYK2 Inhibitors Market: Others (2021-2026) & (K Units)
Figure 25. Global Oral TYK2 Inhibitors Sale Market Share by Application (2025)
Figure 26. Global Oral TYK2 Inhibitors Revenue Market Share by Application in 2026
Figure 27. Oral TYK2 Inhibitors Sales by Company in 2026 (K Units)
Figure 28. Global Oral TYK2 Inhibitors Sales Market Share by Company in 2026
Figure 29. Oral TYK2 Inhibitors Revenue by Company in 2026 ($ millions)
Figure 30. Global Oral TYK2 Inhibitors Revenue Market Share by Company in 2026
Figure 31. Global Oral TYK2 Inhibitors Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Oral TYK2 Inhibitors Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Oral TYK2 Inhibitors Sales 2021-2026 (K Units)
Figure 34. Americas Oral TYK2 Inhibitors Revenue 2021-2026 ($ millions)
Figure 35. APAC Oral TYK2 Inhibitors Sales 2021-2026 (K Units)
Figure 36. APAC Oral TYK2 Inhibitors Revenue 2021-2026 ($ millions)
Figure 37. Europe Oral TYK2 Inhibitors Sales 2021-2026 (K Units)
Figure 38. Europe Oral TYK2 Inhibitors Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Oral TYK2 Inhibitors Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Oral TYK2 Inhibitors Revenue 2021-2026 ($ millions)
Figure 41. Americas Oral TYK2 Inhibitors Sales Market Share by Country in 2026
Figure 42. Americas Oral TYK2 Inhibitors Revenue Market Share by Country (2021-2026)
Figure 43. Americas Oral TYK2 Inhibitors Sales Market Share by Type (2021-2026)
Figure 44. Americas Oral TYK2 Inhibitors Sales Market Share by Application (2021-2026)
Figure 45. United States Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Oral TYK2 Inhibitors Sales Market Share by Region in 2026
Figure 50. APAC Oral TYK2 Inhibitors Revenue Market Share by Region (2021-2026)
Figure 51. APAC Oral TYK2 Inhibitors Sales Market Share by Type (2021-2026)
Figure 52. APAC Oral TYK2 Inhibitors Sales Market Share by Application (2021-2026)
Figure 53. China Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 57. India Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Oral TYK2 Inhibitors Sales Market Share by Country in 2026
Figure 61. Europe Oral TYK2 Inhibitors Revenue Market Share by Country (2021-2026)
Figure 62. Europe Oral TYK2 Inhibitors Sales Market Share by Type (2021-2026)
Figure 63. Europe Oral TYK2 Inhibitors Sales Market Share by Application (2021-2026)
Figure 64. Germany Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 65. France Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Oral TYK2 Inhibitors Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Oral TYK2 Inhibitors Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Oral TYK2 Inhibitors Sales Market Share by Application (2021-2026)
Figure 72. Egypt Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Oral TYK2 Inhibitors in 2026
Figure 78. Manufacturing Process Analysis of Oral TYK2 Inhibitors
Figure 79. Industry Chain Structure of Oral TYK2 Inhibitors
Figure 80. Channels of Distribution
Figure 81. Global Oral TYK2 Inhibitors Sales Market Forecast by Region (2027-2032)
Figure 82. Global Oral TYK2 Inhibitors Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Oral TYK2 Inhibitors Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Oral TYK2 Inhibitors Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Oral TYK2 Inhibitors Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Oral TYK2 Inhibitors Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Oral TYK2 Inhibitors
Figure 2. Oral TYK2 Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral TYK2 Inhibitors Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Oral TYK2 Inhibitors Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Oral TYK2 Inhibitors Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Oral TYK2 Inhibitors Sales Market Share by Country/Region (2025)
Figure 10. Oral TYK2 Inhibitors Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Single-target Inhibitors
Figure 12. Product Picture of Dual-target Inhibitors
Figure 13. Global Oral TYK2 Inhibitors Sales Market Share by Type in 2026
Figure 14. Global Oral TYK2 Inhibitors Revenue Market Share by Type (2021-2026)
Figure 15. Oral TYK2 Inhibitors Consumed in Psoriasis
Figure 16. Global Oral TYK2 Inhibitors Market: Psoriasis (2021-2026) & (K Units)
Figure 17. Oral TYK2 Inhibitors Consumed in Systemic Lupus Erythematosus
Figure 18. Global Oral TYK2 Inhibitors Market: Systemic Lupus Erythematosus (2021-2026) & (K Units)
Figure 19. Oral TYK2 Inhibitors Consumed in Dermatitis
Figure 20. Global Oral TYK2 Inhibitors Market: Dermatitis (2021-2026) & (K Units)
Figure 21. Oral TYK2 Inhibitors Consumed in Arthritis
Figure 22. Global Oral TYK2 Inhibitors Market: Arthritis (2021-2026) & (K Units)
Figure 23. Oral TYK2 Inhibitors Consumed in Others
Figure 24. Global Oral TYK2 Inhibitors Market: Others (2021-2026) & (K Units)
Figure 25. Global Oral TYK2 Inhibitors Sale Market Share by Application (2025)
Figure 26. Global Oral TYK2 Inhibitors Revenue Market Share by Application in 2026
Figure 27. Oral TYK2 Inhibitors Sales by Company in 2026 (K Units)
Figure 28. Global Oral TYK2 Inhibitors Sales Market Share by Company in 2026
Figure 29. Oral TYK2 Inhibitors Revenue by Company in 2026 ($ millions)
Figure 30. Global Oral TYK2 Inhibitors Revenue Market Share by Company in 2026
Figure 31. Global Oral TYK2 Inhibitors Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Oral TYK2 Inhibitors Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Oral TYK2 Inhibitors Sales 2021-2026 (K Units)
Figure 34. Americas Oral TYK2 Inhibitors Revenue 2021-2026 ($ millions)
Figure 35. APAC Oral TYK2 Inhibitors Sales 2021-2026 (K Units)
Figure 36. APAC Oral TYK2 Inhibitors Revenue 2021-2026 ($ millions)
Figure 37. Europe Oral TYK2 Inhibitors Sales 2021-2026 (K Units)
Figure 38. Europe Oral TYK2 Inhibitors Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Oral TYK2 Inhibitors Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Oral TYK2 Inhibitors Revenue 2021-2026 ($ millions)
Figure 41. Americas Oral TYK2 Inhibitors Sales Market Share by Country in 2026
Figure 42. Americas Oral TYK2 Inhibitors Revenue Market Share by Country (2021-2026)
Figure 43. Americas Oral TYK2 Inhibitors Sales Market Share by Type (2021-2026)
Figure 44. Americas Oral TYK2 Inhibitors Sales Market Share by Application (2021-2026)
Figure 45. United States Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Oral TYK2 Inhibitors Sales Market Share by Region in 2026
Figure 50. APAC Oral TYK2 Inhibitors Revenue Market Share by Region (2021-2026)
Figure 51. APAC Oral TYK2 Inhibitors Sales Market Share by Type (2021-2026)
Figure 52. APAC Oral TYK2 Inhibitors Sales Market Share by Application (2021-2026)
Figure 53. China Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 57. India Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Oral TYK2 Inhibitors Sales Market Share by Country in 2026
Figure 61. Europe Oral TYK2 Inhibitors Revenue Market Share by Country (2021-2026)
Figure 62. Europe Oral TYK2 Inhibitors Sales Market Share by Type (2021-2026)
Figure 63. Europe Oral TYK2 Inhibitors Sales Market Share by Application (2021-2026)
Figure 64. Germany Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 65. France Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Oral TYK2 Inhibitors Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Oral TYK2 Inhibitors Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Oral TYK2 Inhibitors Sales Market Share by Application (2021-2026)
Figure 72. Egypt Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Oral TYK2 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Oral TYK2 Inhibitors in 2026
Figure 78. Manufacturing Process Analysis of Oral TYK2 Inhibitors
Figure 79. Industry Chain Structure of Oral TYK2 Inhibitors
Figure 80. Channels of Distribution
Figure 81. Global Oral TYK2 Inhibitors Sales Market Forecast by Region (2027-2032)
Figure 82. Global Oral TYK2 Inhibitors Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Oral TYK2 Inhibitors Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Oral TYK2 Inhibitors Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Oral TYK2 Inhibitors Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Oral TYK2 Inhibitors Revenue Market Share Forecast by Application (2027-2032)
